if thats the case the market should start the accumilation of ariad stock, not selling them! what does the market know? does anyone think it will be a underachieving 1st quarter sales? is that why insiders are dumping?
not sure if this is proper venue for other biotech stocks-but stocks i believe are heading higher in short term are snta-xoma-xnpt(quickly-as biib drug is approved this week)cers